Skip to main content

Nulecit Side Effects

Generic name: sodium ferric gluconate complex

Medically reviewed by Last updated on Jun 6, 2023.

Note: This document contains side effect information about sodium ferric gluconate complex. Some dosage forms listed on this page may not apply to the brand name Nulecit.

Applies to sodium ferric gluconate complex: intravenous solution.

Serious side effects of Nulecit

Along with its needed effects, sodium ferric gluconate complex (the active ingredient contained in Nulecit) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking sodium ferric gluconate complex:

More common

Incidence not known

Other side effects of Nulecit

Some side effects of sodium ferric gluconate complex may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Incidence not known

For Healthcare Professionals

Applies to sodium ferric gluconate complex: intravenous solution.


The most common adverse events were nausea, vomiting, diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, abnormal erythrocytes (changes in morphology, color, or number of red blood cells), dyspnea, chest pain, leg cramps, pain, headache, and tachycardia.[Ref]


Very common (10% or more): Hypotension (35%), hypertension (23%), tachycardia (17%)

Common (1% to 10%): Thrombosis

Frequency not reported: Bradycardia, vasodilatation, angina pectoris, myocardial infarction

Postmarketing reports: Hemorrhage, shock, phlebitis[Ref]


Very common (10% or more): Nausea/vomiting and/or diarrhea (35%)

Common (1% to 10%): Abdominal pain

Frequency not reported: Rectal disorder, dyspepsia, eructation, flatulence, gastrointestinal disorder, melena

Postmarketing reports: Dry mouth[Ref]


Very common (10% or more): Injection site reaction (33%)[Ref]


Postmarketing reports: Allergic reaction, anaphylactic-type reactions[Ref]

Nervous system

Very common (10% or more): Headache (24%), dizziness (13%)

Common (1% to 10%): Headache, paresthesias, syncope

Frequency not reported: Lightheadedness, somnolence, decreased level of consciousness

Postmarketing reports: Hypertonia, loss of consciousness, convulsion, dysgeusia, hypoesthesia[Ref]


Very common (10% or more): Cramps (25%), leg cramps (10%)

Frequency not reported: Myalgia, arthralgia, back pain, arm pain[Ref]


Very common (10% or more): Dyspnea (11%)

Common (1% to 10%): Coughing, upper respiratory infections, pharyngitis, rhinitis

Frequency not reported: Pneumonia, pulmonary edema[Ref]


Common (1% to 10%): Pruritus

Frequency not reported: Rash, increased sweating

Postmarketing reports: Skin discoloration[Ref]


Very common (10% or more): Abnormal erythrocytes (changes in morphology, color, or number of red blood cells) (11%)

Frequency not reported: Anemia, leukocytosis, lymphadenopathy[Ref]


Very common (10% or more): Chest pain (10%), pain (10%)

Common (1% to 10%): Asthenia, fatigue, fever, malaise, infection, generalized edema

Frequency not reported: Infection, abscess, chills, rigors, flu-like syndrome, weakness, deafness, leg edema, peripheral edema, edema[Ref]


Common (1% to 10%): Hyperkalemia

Frequency not reported: Anorexia, hypoglycemia, hypervolemia, hypokalemia[Ref]


Common (1% to 10%): Infection

Frequency not reported: Sepsis[Ref]


Frequency not reported: Urinary tract infection, menorrhagia[Ref]


Frequency not reported: Agitation

Postmarketing reports: Nervousness[Ref]


Frequency not reported: Carcinoma[Ref]


Frequency not reported: Conjunctivitis, rolling of the eyes, watery eyes, puffy eye lids, arcus senilis, diplopia[Ref]


1. Product Information. Ferrlecit (sodium ferric gluconate complex). sanofi-aventis. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.